Articles about Remdesivir

COVID-19: Centre to discontinue allocation of Remdesivir to states

29 May 2021

COVID-19: Centre to discontinue allocation of Remdesivir to states

The Indian government has decided to stop the central allocation of Remdesivir to states, citing sufficient supply of the antiviral drug being used to treat severe coronavirus patients.

Student duped victims of over Rs. 2L for Remdesivir, held

28 May 2021

Student duped victims of over Rs. 2L for Remdesivir, held

An 18-year-old college student was arrested from Madhya Pradesh for allegedly cheating people on the pretext of providing them Remdesivir injections, Delhi police said on Friday.

Keep stocks ready for third wave, government tells pharmaceutical firms

19 May 2021

Keep stocks ready for third wave, government tells pharmaceutical firms

The Indian government has told top pharmaceutical companies in the country to start preparing for a third wave of the coronavirus pandemic and stock up key drugs in a span of the next two-three months.

Remdesivir may be dropped from COVID-19 treatment, says Gangaram doctor

19 May 2021

Remdesivir may be dropped from COVID-19 treatment, says Gangaram doctor

The use of Remdesivir may soon be dropped from the government guidelines concerning COVID-19 treatment in India, a top doctor based in Delhi has said.

MP: Crash landing of plane carrying Remdesivir to be probed

07 May 2021

MP: Crash landing of plane carrying Remdesivir to be probed

Aviation experts will conduct a probe into the crash-landing of a Madhya Pradesh government plane carrying a stock of anti-viral drug Remdesivir at Gwalior Airport following a technical snag, a senior official said on Friday.

Delhi: Man arrested for duping people for oxygen cylinders, Remdesivir

04 May 2021

Delhi: Man arrested for duping people for oxygen cylinders, Remdesivir

A 24-year-old man was arrested on Tuesday from Faridabad for allegedly duping people on the pretext of providing oxygen cylinders and Remdesivir injections, police said.

Gujarat: 90 Remdesivir vials worth Rs. 5 lakh seized

29 Apr 2021

Gujarat: 90 Remdesivir vials worth Rs. 5 lakh seized

Five persons were arrested on Wednesday in Gujarat with 90 Remdesivir injections worth Rs. 4.86 lakh which they were planning to sell in the black market, police officials said.

How are individuals procuring, selling Remdesivir? Bombay HC asks Centre

27 Apr 2021

How are individuals procuring, selling Remdesivir? Bombay HC asks Centre

The Bombay High Court on Tuesday asked the federal government how private individuals were procuring and selling the crucial drug, Remdesivir.

Gilead announces steps to expand availability of Remdesivir in India

27 Apr 2021

Gilead announces steps to expand availability of Remdesivir in India

American biopharmaceutical company Gilead has announced several steps to expand the availability of Remdesivir, which is a key therapeutic medicine used in the treatment of COVID-19 patients, in India.

Delhi: Five arrested for black-marketing of Remdesivir injection

26 Apr 2021

Delhi: Five arrested for black-marketing of Remdesivir injection

Five people have been arrested from different parts of Delhi for their alleged involvement in black-marketing of Remdesivir injection amid its heightened demand due to surging coronavirus cases, police said.

Government issues updated clinical guidance for management of COVID-19 patients

23 Apr 2021

Government issues updated clinical guidance for management of COVID-19 patients

The Union Health Ministry has issued an updated "Clinical Guidance for Management of Adult COVID-19 Patients" recommending emergency use authorization of Remdesivir for patients with moderate to severe diseases, requiring supplemental oxygen, within ten days of onset of symptoms.

Coronavirus: Centre to supply Remdesivir to 19 worst-hit states

22 Apr 2021

Coronavirus: Centre to supply Remdesivir to 19 worst-hit states

As India witnesses a huge demand for the antiviral drug Remdesivir amid a sharp surge in COVID-19 cases, the central government has announced an interim allocation of the drug to 19 states and Union Territories until April 30.

Book those black-marketing medicines like Remdesivir under NSA: Adityanath

21 Apr 2021

Book those black-marketing medicines like Remdesivir under NSA: Adityanath

Uttar Pradesh Chief Minister Yogi Adityanath on Wednesday directed officials to conduct raids on those involved in black-marketing of medicines like Remdesivir and book offenders under the National Security Act (NSA).

2,200 Remdesivir vials stocked by exporters seized in Mumbai

20 Apr 2021

2,200 Remdesivir vials stocked by exporters seized in Mumbai

Police and Food and Drug Administration (FDA) officials raided two locations in Mumbai and seized 2,200 vials of Remdesivir stocked by exporters, an official said on Tuesday.

Maharashtra BJP accused of illegally procuring Remdesivir; here's what happened

19 Apr 2021

Maharashtra BJP accused of illegally procuring Remdesivir; here's what happened

Even as the COVID-19 outbreak gets progressively worse in Maharashtra, the state is witnessing a fresh controversy over the alleged illegal procurement of the anti-viral drug Remdesivir by the Bharatiya Janata Party (BJP).

Not afraid of inquiry: Fadnavis on pharma firm-Remdesivir issue

19 Apr 2021

Not afraid of inquiry: Fadnavis on pharma firm-Remdesivir issue

BJP leader Devendra Fadnavis, who is being targeted by the ruling parties in Maharashtra for objecting to Mumbai police's grilling of a pharma company's top executive over alleged stocking of Remdesivir vials, on Sunday said he was not afraid of any inquiry against him as he has not done anything wrong.

COVID-19 drug Remdesivir's price must not cross Rs. 1400: Tope

09 Apr 2021

COVID-19 drug Remdesivir's price must not cross Rs. 1400: Tope

The Maharashtra government on Thursday decided to cap the price of Remdesivir between Rs. 1,100 and Rs. 1,400 per vial with Health Minister Rajesh Tope calling for slashing the MRP of the key COVID-19 drug.

Remdesivir found ineffective; India to reassess coronavirus treatment protocol

17 Oct 2020

Remdesivir found ineffective; India to reassess coronavirus treatment protocol

The second worst-hit nation in coronavirus pandemic, India, that takes pride in the remarkable recovery rate, will reassess coronavirus treatment protocol after a large-scale trial conducted by World Health Organization (WHO) found that four commonly used re-purposed drugs had little impact in reducing mortality.

Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India

13 Aug 2020

Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India

In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.

Study identifies 21 existing drugs that could treat COVID-19

25 Jul 2020

Study identifies 21 existing drugs that could treat COVID-19

A recent study identified 21 existing drugs that could be used to treat COVID-19. The drugs can notably stop the replication of SARS-CoV-2, the coronavirus that causes COVID-19, the study found.

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

25 Jun 2020

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

Five states across India will be the first to receive Hetero Healthcare's COVID-19 drug, COVIFOR, the first generic brand of the experimental drug remdesivir.

These drugs are in use for COVID-19 treatment in India

24 Jun 2020

These drugs are in use for COVID-19 treatment in India

India has opened up, but the pandemic is not slowing down.

Health Ministry adds loss of smell, taste to COVID-19 symptoms

13 Jun 2020

Health Ministry adds loss of smell, taste to COVID-19 symptoms

The Health Ministry has expanded the list of symptoms of COVID-19 to include the loss of smell and taste.

Remdesivir reportedly approved for COVID-19 treatment in India

02 Jun 2020

Remdesivir reportedly approved for COVID-19 treatment in India

Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.

Noida-based Jubilant to make COVID-19 drug Remdesivir in India

13 May 2020

Noida-based Jubilant to make COVID-19 drug Remdesivir in India

Noida-based Jubilant Life Sciences has announced a licensing agreement with Gilead to make Remdesivir, a drug that has shown promise in treating COVID-19, in India.

Modi orders drug regulatory system overhaul to reduce red tape

06 May 2020

Modi orders drug regulatory system overhaul to reduce red tape

At a Tuesday meeting to discuss India's drug discovery, testing, and vaccine response to COVID-19, Prime Minister Narendra Modi reportedly suggested drug regulatory reforms.

India gears up to develop key COVID-19 drug: Details here

05 May 2020

India gears up to develop key COVID-19 drug: Details here

The US recently approved Remdesivir, a key antiviral drug from Gilead Sciences, for emergency use on COVID-19 patients.

Coronavirus: US study on remdesivir inconclusive, says Health Ministry

30 Apr 2020

Coronavirus: US study on remdesivir inconclusive, says Health Ministry

The Ministry of Health and Family Welfare on Thursday said that a study conducted on an antiviral drug in the United States for COVID-19 treatment is inconclusive.

New COVID-19 drug has 'clear cut' positive effect: Dr. Fauci

30 Apr 2020

New COVID-19 drug has 'clear cut' positive effect: Dr. Fauci

The US government's top infectious disease expert, Dr. Anthony Fauci said that a new COVID-19 drug has proven to be quite a 'good news' in clinical trials.